Liu Linda 4
4 · NextCure, Inc. · Filed Mar 3, 2020
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Liu Linda
SVP, Research
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-02-28+39,100→ 39,100 totalExercise: $41.76Exp: 2030-02-27→ Common Stock (39,100 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on February 28, 2021. The remainder vests in 36 monthly installments beginning on March 28, 2021.